CHOZN® Platform
Source: MilliporeSigma
Generating and isolating high-producing cell lines or clones can be costly and labor-intensive. Instead, free your R&D to focus on developing new therapeutics by outsourcing the engineering of production cell lines to our CHOZN® Platform Development Team of highly trained scientists.
We can support your biomanufacturing and research with years of expertise in genome editing for Chinese hamster ovary (CHO) cell lines. Our customized services use a variety of molecular biology methods, including our own CompoZr® zinc finger nuclease (ZFN) technology, to deliver efficient cell lines that help reduce product costs and timelines.
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more